Cardiac Papillary Fibroelastoma: Single-Institution Experience with 14 Surgical Patients
Key result
Surgical resection of cardiac papillary fibroelastoma is safe, yielding 0% 30-day mortality without valve replacement.
- n=14
Why the study?
Few institutions have sufficient experience with cardiac papillary fibroelastoma to validate the surgical resection approach, especially for left-sided lesions.
What are the clinical characteristics and surgical outcomes of patients with cardiac papillary fibroelastoma?
Population
14 patients diagnosed with cardiac papillary fibroelastoma from 1992 through 2014
Comparison
Surgical resection of left-sided and right-sided papillary fibroelastomas
Design
Single-institution observational case series
Follow-up
1 year
Authors
Discussion
Loading...
Member takes
Implication
Supports safe resection of left-sided papillary fibroelastomas in surgical candidates; leaves open management of right-sided or asymptomatic lesions.
Study Design
Type
Observational (n=14)
Multicenter
No
Structured PICO
What are the clinical characteristics and surgical outcomes of patients with cardiac papillary fibroelastoma?
P
Population
14 patients (mean age 60.5 years) diagnosed with cardiac papillary fibroelastoma who underwent surgical resection between 1992 and 2014.
E
Exposure
Surgical resection
O
Outcome
Operative or 30-day deaths, need for valve replacement postoperatively, late death, and tumor recurrencehard clinical
Surgical resection of cardiac papillary fibroelastomas, particularly left-sided lesions, is safe and associated with good postoperative outcomes without the need for valve replacement.
Limitations
- Could not always definitively associate symptoms with a cardiac tumor
- 3 patients were lost to follow-up at one year
Cite This Study
Saleh et al. (2016) conducted an observational in Cardiac papillary fibroelastoma (n=14). Surgical resection was evaluated on Operative or 30-day deaths. Surgical resection of cardiac papillary fibroelastoma in 14 patients resulted in 0 operative or 30-day deaths and no need for postoperative valve replacement.